Table 5.
Logistic regression analysis to determine melatonin use associated with sepsis in COVID-19 patients.
| B | SE | Wald | df | Sig. | Exp. (B) | 95% CI for Exp (B) | ||
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Melatonin | -2.642 | 0.624 | 17.949 | 1 | 0.000* | 0.071 | 0.021 | 0.242 |
| Age | 0.157 | 0.046 | 11.766 | 1 | 0.001* | 1.170 | 1.070 | 1.279 |
| Gender | -0.563 | 0.620 | 0.825 | 1 | 0.364 | 0.569 | 0.169 | 1.920 |
| Hypertension | -0.520 | 0.556 | 0.876 | 1 | 0.349 | 0.594 | 0.200 | 1.766 |
| Ischemic heart disease | 0.622 | 0.661 | 0.885 | 1 | 0.347 | 1.862 | 0.510 | 6.803 |
| Diabetes mellitus | 2.243 | 0.597 | 14.131 | 1 | 0.000* | 9.418 | 2.925 | 30.322 |
| Asthma | 1.829 | 0.798 | 5.250 | 1 | 0.022* | 6.225 | 1.303 | 29.744 |
| Constant | -12.918 | 2.910 | 19.704 | 1 | 0.000* | 0.000 | ||
B, coefficient; SE, standard error of B; df, degree of freedom; Exp (B), estimated odds ratio; CI, confidence interval for exp (B)
*Significant using binary logistic regression